Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CTV 05

Next Previous
X
Search
Drug Profile

CTV 05

Alternative Names: CTV-05; LACTIN-V; Lactobacillus crispatus CTV-05

Latest Information Update: 03 May 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GyneLogix
  • Developer National Institute of Allergy and Infectious Diseases; Osel Inc; The Fertility Clinic, Skive; University of Washington
  • Class Probiotics
  • Mechanism of Action Bacteria replacements; Vaginal microbiome modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Urinary tract infections
  • Phase II Bacterial vaginosis

Most Recent Events

  • 03 Mar 2024 Efficacy and adverse event data from a phase II trial in Bacterial vaginosis presented at the 31st Conference on Retroviruses and Opportunistic Infections 2024 (CROI-2024)
  • 16 Aug 2023 The Fertility Clinic, Skive completes the phase II trial inBacterial vaginosis in Denmark (Vaginal) (NCT05166746) (EudraCT2016-002385-31)
  • 10 May 2021 Phase-II clinical trials in Bacterial vaginosis in South Africa (Vaginal) (NCT05022212)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top